POS-095 URIC ACID LEVEL AFTER KIDNEY TRANSPLANTATION AND LONG-TERM EFFECT ON GRAFT SURVIVAL

Determinants of Long-Term Graft and Patient Survival after Transplantation of Kidney and Liver

Re: Hyperlipidemia after kidney transplantation: long-term graft outcome.

Dear Editor, We read with interest the article by Raees-Jalali and colleagues1 recently published in the Iranian Journal of Kidney Diseases, titled “Hyperlipidemia after kidney transplantation: long-term graft outcome.” They evaluated the prevalence of hyperlipidemia and its relation with renal allograft function within 10 years of follow-up among 73 kidney transplant patients in a single cente...

Hyperlipidemia after kidney transplantation: long-term graft outcome.

INTRODUCTION Metabolic complications are common after kidney transplantation and can cause considerable morbidity and even threaten graft function. This study aimed to investigate the prevalence of hyperlipidemia and its impact on graft function in 10 years of follow-up of patients undergoing kidney transplantation. MATERIALS AND METHODS This prospective study was conducted on 73 patients who...

Kidney and recipient weight incompatibility reduces long-term graft survival.

Long-term function of kidney allografts depends on multiple variables, one of which may be the compatibility in size between the graft and the recipient. Here, we assessed the long-term consequences of the ratio of the weight of the kidney to the weight of the recipient (KwRw ratio) in a multicenter cohort of 1189 patients who received a transplant between 1995 and 2006. The graft filtration ra...

Clinical and histological predictors of long-term kidney graft survival.

Renal transplantation is the best option for patients with end-stage renal disease (ESRD), but its half-life is limited to a decade. Clinical and histological markers measurable within the first year of transplantation can be used to predict its outcome. These markers are important for selecting kidneys for transplantation, for identifying the main causes of late allograft loss, for therapeutic...